CLINICAL_TRIALS
trial_result
· 2011-03-11
Clinical Trial Update: Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics [Phase 4]
Summary
The Phase 4 trial evaluating Ambisome for culture-negative neutropenic fever unresponsive to antibiotics was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Febrile Neutropenia | Phase 4 | Status: TERMINATED